IGM Biosciences, Inc. (IGMS)

IGM Biosciences Revenue

IGM Biosciences had revenue of $2.11M in the twelve months ending March 31, 2024, with 32.31% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $497.00K, a -4.79% decrease year-over-year. In the year 2023, IGM Biosciences had annual revenue of $2.13M with 99.25% growth.

• Revenue (ttm): $2.11M
• Revenue Growth: +32.31%
• P/S Ratio: 179.45
• Revenue / Employee: $9,745
• Employees: 216
• Market Cap: 377.75M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	2.13M	1.06M	99.25%
Dec 31, 2022	1.07M	-	-
Dec 31, 2021	0	-	-
Dec 31, 2020	0	-	-
Dec 31, 2019	0	-	-
Dec 31, 2018	0	-	-
Dec 31, 2017	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.